Cabell Huntington Hospital
Huntington, West Virginia, 25701, United States
NCT Number: NCT03235193
In this prospective study, the ability of a machine learning algorithm to predict sepsis and influence clinical outcomes, will be investigated at Cabell Huntington Hospital (CHH).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Huntington, West Virginia, 25701, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Upon receiving an InSight alert, healthcare provider follows standard practices in assessing possible (severe) sepsis and intervening accordingly.
Upon receiving information from the severe sepsis detector in the CHH electronic health record, healthcare provider follows standard practices in assessing possible (severe) sepsis and intervening accordingly.
Time frame: Through study completion, an average of 30 days
Time frame: Through study completion, an average of 30 days
Time frame: Through study completion, an average of 30 days
Time frame: Through study completion, an average of 30 days
Dascena
Industry
Prediction of Severe Sepsis Using a Machine Learning Algorithm
Acronym: PREVISE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00793442
Infections, Inflammation
Birmingham, Alabama, United States
View Trial DetailsNCT03077672
Disease Attributes, Emergencies
Brooklyn, New York, United States
View Trial DetailsNCT03996720
Infections, Inflammation
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03015454
Infections, Inflammation
San Francisco, California, United States
View Trial Details